Cargando…
Review on the Structures and Activities of Transthyretin Amyloidogenesis Inhibitors
Transthyretin (TTR) is a tetrameric protein, and its dissociation, aggregation, deposition, and misfolding are linked to several human amyloid diseases. As the main transporter for thyroxine (T4) in plasma and cerebrospinal fluid, TTR contains two T4-binding sites, which are docked with T4 and subse...
Autores principales: | Guo, Xiaohua, Liu, Zhaowen, Zheng, Yizhou, Li, Yamei, Li, Linfu, Liu, Hai, Chen, Zhixi, Wu, Longhuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071892/ https://www.ncbi.nlm.nih.gov/pubmed/32210536 http://dx.doi.org/10.2147/DDDT.S237252 |
Ejemplares similares
-
Plasminogen activation triggers transthyretin amyloidogenesis in vitro
por: Mangione, P. Patrizia, et al.
Publicado: (2018) -
A molecular mechanism for transthyretin amyloidogenesis
por: Yee, Ai Woon, et al.
Publicado: (2019) -
Repositioning tolcapone as a potent inhibitor of transthyretin amyloidogenesis and associated cellular toxicity
por: Sant'Anna, Ricardo, et al.
Publicado: (2016) -
Development
of
a Highly Potent Transthyretin Amyloidogenesis
Inhibitor: Design, Synthesis, and Evaluation
por: Pinheiro, Francisca, et al.
Publicado: (2022) -
TMF inhibits miR-29a/Wnt/β-catenin signaling through upregulating Foxo3a activity in osteoarthritis chondrocytes
por: Huang, Xianhua, et al.
Publicado: (2019)